Clinical Trial Update: Evaluation of Effective Lens Position With a Uniplanar Bi-aspheric IOL [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effective lens position of a Uniplanar Bi-aspheric Intraocular Lens in cataract patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Uniplanar Bi-aspheric Intraocular Lens (intraocular lens (IOL))

Snippet

Sponsor: Lenstec Incorporated | Conditions: Cataract | Phase 4 | Status: COMPLETED